OrbiMed Advisors Israel II Ltd
SEC CIK 1682093 · EDGAR
BoughtSold
Most active insiders at ACET, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ORBIMED ADVISORS LLC | 10% | $5.00M | $674.8K |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 10% | $1.60M | — |
| 3 | Aftab Blake | CSO | — | — |
| 4 | Healey Don | CTO | — | — |
| 5 | Harvey Brian Nicholas | CFO | — | — |
| 6 | Schor Chen | Pres, CEO, Dir | — | — |
OrbiMed Advisors Israel II Ltd made no open-market trades at ACET in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-01-26 | 2024-01-25 | ACET | Adicet Bio, Inc. | OrbiMed Advisors Israel II Ltd | Dir, 10% | P - Purchase | $2.40 | +3.12M | 7.53M | +71% | +$7.50M |
| MI | 2023-08-17 | 2023-08-15 | DMRA | Damora Therapeutics, Inc. | OrbiMed Advisors Israel II Ltd | 10% | S - Sale | $0.75 | -822.7K | 631.0K | -57% | -$617.0K |
| MI | 2023-07-17 | 2023-07-13 | DMRA | Damora Therapeutics, Inc. | OrbiMed Advisors Israel II Ltd | 10% | S - Sale | $2.40 | -194.7K | 914.3K | -18% | -$467.3K |
| MI | 2023-04-12 | 2023-04-10+ | DMRA | Damora Therapeutics, Inc. | OrbiMed Advisors Israel II Ltd | 10% | S - Sale | $1.80 | -67.5K | 985.6K | -6% | -$121.4K |
Purchase Sale Sale after option exercise All abbreviations